多发性硬化症中的阿迪波金:免疫失调,神经炎症和治疗机会
Elham Moases Ghaffary1, Geir Bjørklund2, Ramesa Shafi Bhat3
1Division of Pharmacology and Pharmaceutical Sciences, University of Missouri-Kansas City School of Pharmacy, Kansas City, MO, USA.
Autoimmunity reviews
|May 1, 2025
概括
脂肪组织中的信号分子阿迪波金在多发性硬化症 (MS) 中起着双重作用. 一些通过促进炎症和破坏血脑屏障恶化MS,而另一些则提供神经保护,表明它们作为生物标志物和治疗点的潜力.
科学领域:
- 神经免疫学 神经免疫学
- 代谢途径 代谢途径
- 中枢神经系统 (CNS) 疾病
背景情况:
- 多发性硬化症 (MS) 是一种慢性中枢神经系统自身免疫性疾病,其特征是脱髓化和神经炎症.
- 由脂肪组织分泌的阿迪波金素显著影响免疫和代谢功能.
- 像抵抗素,瘦素和化学素这样的调节失调的皮素通过促进T细胞炎症和破坏血脑屏障 (BBB) 完整性来加剧MS.
研究的目的:
- 调查阿迪波金在MS病理生理学和管理中的多方面的作用.
- 探索阿迪波金作为MS诊断/预后生物标志物的潜力.
- 评估阿迪波金作为MS的治疗点.
主要方法:
- 对MS中阿迪波金功能的临床前和翻译研究结果的审查.
- 在临床MS环境中对阿迪波金表达模式的分析.
- 考虑生活方式和药物干预措施,以向adipokine配置文件.
主要成果:
- 阿迪波金在MS中表现出相反的效果:有些是促炎和神经毒性,而阿迪波内克丁表现出免疫调节和神经保护性质.
- 阿迪波金 (adipokine) 概况与MS预后和诊断相关.
- 调节阿迪波金水平可能补充现有的疾病修饰治疗 (DMT).
结论:
- 阿迪波金是MS免疫代谢的关键参与者,影响T细胞,质细胞和BBB功能.
- 阿迪波金具有作为MS生物标志物和治疗点的巨大潜力.
- 对阿迪波金介导的免疫代谢调节的进一步研究对于推进MS治疗至关重要.
相关概念视频
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Multiple Sclerosis l: Introduction
31
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31


